JEFFSHAN JOHN PONNARASU: Open Payments
NPI 1003677220 · CHERAW, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 48 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $330 · 2025 $838
Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $300 |
| Corcept Therapeutics | 5 | $115 |
| Xeris Pharmaceuticals, Inc. | 4 | $79 |
| Novartis Pharmaceuticals Corporation | 2 | $62 |
| Novo Nordisk Inc | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Exact Sciences Corporation | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
| Amgen Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
Products named: VRAYLAR, Korlym, UBRELVY, RECORLEV, LEQVIO, Ozempic, Cologuard Collection Kit, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
